Striving to provide balanced, scientific content related to care of patients with GU malignancies
THE UROMIGOS SCORE
We polled experts from 13 countries regarding the value of different treatment options in various advanced GU cancer disease states.
As not all drugs have the same clinical impact despite getting similar guideline levels of recommendation, the Uromigos Score is designed to quantify clinical support for various approaches. We asked each expert to score a given treatment according to the following:
3: Undisputed SOC
2: Potentially inferior to SOC but a reasonable option
1: Has a limited role
0: Should be avoided
We assumed patients are fit/eligible/appropriate for all treatment options without contraindications, preferences, or limitations of availability/funding. The mean of all scores is presented.
